There is no IP issue. This keeps getting brought up by one person who I have on ignore so I don't see their posts but am assuming they brought it up again since you are asking this question. I think we are approaching a year now of that question being asked multiple times with said individual refusing to do any DD or elaborating on the issue even though links to the licensing agreements and patents have been posted.
Mana Therapeutics will have a big problem on their hand if they ever try to market anything.
Catherine Bollard used to work at BCM. She helped Ann Leen and Juan Vera although she did not have an integral part in developing the MultiTAA therapy. When she left for Texas Children's Hospital? she wanted to continue the work she was helping with at BCM and Dr. Leen allowed her to do so in a clinical capacity. She chose to effectively steal the idea and start Mana. They are not the only company to have infringed on Marker's IP but Marker is aware of it. If they try to take anything to market they will be dealt with.
That being said Marker's plan right now is to beat them to market which is obviously likely as Marker is way ahead of Mana. At this point this is the only thing they can really do that will have much effect since I don't believe any lawsuits can be brought against Mana as the work is all clinical.
News 
Market Data 
Discover 
AI
